Products

Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant human CSF1R /CD115 Protein, Fc Tag, 200µg  

Recombinant human CSF1R /CD115 Protein, Fc Tag, 200µg

Recombinant Human M-CSF R / CSF1R /CD115 Protein, Ile 20 - Glu 512, produced in human 293 cells (HEK293), Fc Tag, low endotoxin 

Synonym
Recombinant Human Protein, CSF1R, C-FMS, CD115, CSFR, FIM2, FMS, M-CSFR

More details

CSR-H5258-200

Availability: within 7 days

336,00 €

Background
Colony stimulating factor 1 receptor (CSF1R), also known as macrophage colony-stimulating factor receptor (M-CSFR), CD115 Cluster of Differentiation 115 (CD115), C-FMS, CSFR, FIM2, FMS, and is a member of the type III subfamily of receptor tyrosine kinases (RTKs). CSF1R is a receptor for a cytokine called colony stimulating factor 1, The protein encoded by the CSFR1 gene is the receptor for colony stimulating factor 1, a cytokine which controls the production, differentiation, and function of macrophages. This receptor mediates most, if not all, of the biological effects of this cytokine. Ligand binding activates CSFR1 through a process of oligomerization and transphosphorylation. Mutations in CSF1R are associated with chronic myelomonocytic leukemia and type M4 acute myeloblastic leukemia. Increased levels of CSF1R1 are found in microglia in Alzheimer\'s disease and after brain injuries. The increased receptor expression causes microglia to become more active. Both CSF1R, and its ligand colony stimulating factor 1 play an important role in the development of the mammary gland and may be involved in the process of mammary gland carcinogenesis.

Source
Recombinant Human M-CSF R, Fc Tag, low endotoxin (CSR-H5258) is expressed from human 293 cells (HEK293). It contains AA Ile 20 - Glu 512 (Accession # NP_005202.2).
Predicted N-terminus: Ile 20.

Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 80.6 kDa. The protein migrates as 100-150 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg of the rhCSF1R-Fc by the LAL method.

Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet

Clinical and Translational Updates

(1) "Postoperative Pulmonary Hemodynamics and Systemic Inflammatory Response in Pediatric Patients Undergoing Surgery for Congenital Heart Defects"
Souza, Penha, Maeda et al
Mediators Inflamm (2022) 2022, 3977585
(2) "Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells"
Roufarshbaf, Esmaeil, Akbari
Res Pharm Sci (2022) 17 (1), 43-52
(3) "Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species"
Soto-Diaz, Vailati-Riboni, Louie et al
Front Immunol (2021) 12, 734349
Showing 1-3 of 1283 papers.